Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 86

    1.

    An approach to evaluating the therapeutic misconception.

    Kim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG.

    IRB. 2009 Sep-Oct;31(5):7-14. No abstract available. PMID: 19873836 [PubMed - indexed for MEDLINE]Related articles

    2.

    Financing of U.S. biomedical research and new drug approvals across therapeutic areas.

    Dorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H 3rd.

    PLoS One. 2009 Sep 11;4(9):e7015.PMID: 19750225 [PubMed - in process]Related articlesFree article

    3.

    Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.

    Yurcheshen ME, Guttuso T Jr, McDermott M, Holloway RG, Perlis M.

    J Womens Health (Larchmt). 2009 Sep;18(9):1355-60.PMID: 19708803 [PubMed - indexed for MEDLINE]Related articles

    4.

    Selegiline shortage: Causes and costs of a generic drug shortage.

    Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG.

    Neurology. 2009 Jul 21;73(3):213-7.PMID: 19620609 [PubMed - indexed for MEDLINE]Related articles

    5.

    Patient and organizational factors related to education and support use by Veterans with Parkinson's disease.

    Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP.

    Mov Disord. 2009 Oct 15;24(13):1916-24.PMID: 19606487 [PubMed - in process]Related articles

    6.

    A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association.

    Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA 4th, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR; American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease.

    Stroke. 2009 Jul;40(7):2616-34. Epub 2009 May 7. Review.PMID: 19423852 [PubMed - indexed for MEDLINE]Related articles

    7.

    Funding of Parkinson research from industry and US federal and foundation sources.

    Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H 3rd.

    Mov Disord. 2009 Apr 15;24(5):731-7.PMID: 19133662 [PubMed - indexed for MEDLINE]Related articles

    8.

    When disclosures are more interesting than the evidence.

    Holloway RG, Benesch C.

    Stroke. 2009 Feb;40(2):e44; author reply e45. Epub 2008 Dec 18. No abstract available. PMID: 19095995 [PubMed - indexed for MEDLINE]Related articles

    9.

    A cost-utility comparison of four first-line medications in painful diabetic neuropathy.

    O'Connor AB, Noyes K, Holloway RG.

    Pharmacoeconomics. 2008;26(12):1045-64. doi: 10.2165/0019053-200826120-00007.PMID: 19014205 [PubMed - indexed for MEDLINE]Related articles

    10.

    Public reporting of quality data for stroke: is it measuring quality?

    Kelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG.

    Stroke. 2008 Dec;39(12):3367-71. Epub 2008 Sep 4.PMID: 18772446 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Quantitative risk-benefit analysis of natalizumab.

    Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG.

    Neurology. 2008 Jul 29;71(5):357-64.PMID: 18663181 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Trust in early phase research: therapeutic optimism and protective pessimism.

    Kim SY, Holloway RG, Frank S, Wilson R, Kieburtz K.

    Med Health Care Philos. 2008 Dec;11(4):393-401. Epub 2008 Jul 16.PMID: 18629609 [PubMed - indexed for MEDLINE]Related articles

    13.

    Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.

    Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO.

    Neurology. 2008 Jul 1;71(1):57-63.PMID: 18591506 [PubMed - indexed for MEDLINE]Related articles

    14.

    Invited article: Neurology and quality improvement: an introduction.

    Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC.

    Neurology. 2008 Apr 29;70(18):1636-40. No abstract available. PMID: 18443315 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ethics of sham surgery: perspective of patients.

    Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY.

    Mov Disord. 2008 Jan;23(1):63-8.PMID: 17960809 [PubMed - indexed for MEDLINE]Related articles

    16.

    Quality of life in epilepsy, multiple sclerosis, and beyond.

    Dorsey ER, Holloway RG.

    Ann Neurol. 2007 Oct;62(4):307-8. No abstract available. PMID: 17868099 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mortality as a measure of quality: implications for palliative and end-of-life care.

    Holloway RG, Quill TE.

    JAMA. 2007 Aug 15;298(7):802-4. No abstract available. PMID: 17699014 [PubMed - indexed for MEDLINE]Related articles

    18.

    A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.

    O'Connor AB, Noyes K, Holloway RG.

    J Am Geriatr Soc. 2007 Aug;55(8):1176-84. Review.PMID: 17661955 [PubMed - indexed for MEDLINE]Related articles

    19.

    Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.

    Biglan KM, Holloway RG Jr, McDermott MP, Richard IH; Parkinson Study Group CALM-PD Investigators.

    Neurology. 2007 Jul 10;69(2):187-95.PMID: 17620552 [PubMed - indexed for MEDLINE]Related articles

    20.

    The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation.

    Noyes K, Dick AW, Holloway RG.

    Med Decis Making. 2007 May-Jun;27(3):327-34. Epub 2007 May 14.PMID: 17502449 [PubMed - indexed for MEDLINE]Related articles

    21.

    Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis.

    Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR.

    Neurology. 2007 May 1;68(18):1524-8.PMID: 17470756 [PubMed - indexed for MEDLINE]Related articles

    22.

    Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients.

    Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE.

    Crit Care Med. 2007 Jun;35(6):1530-5.PMID: 17452930 [PubMed - indexed for MEDLINE]Related articles

    23.

    Health care costs decline after successful epilepsy surgery.

    Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S.

    Neurology. 2007 Apr 17;68(16):1290-8.PMID: 17438219 [PubMed - indexed for MEDLINE]Related articles

    24.

    The safety of hospital stroke care.

    Holloway RG, Tuttle D, Baird T, Skelton WK.

    Neurology. 2007 Feb 20;68(8):550-5.PMID: 17310024 [PubMed - indexed for MEDLINE]Related articles

    25.

    Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?

    Little DM, Holloway RG.

    Neurology. 2007 Jan 2;68(1):9-10. No abstract available. PMID: 17200483 [PubMed - indexed for MEDLINE]Related articles

    26.

    Financial anatomy of neuroscience research.

    Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H 3rd.

    Ann Neurol. 2006 Dec;60(6):652-9. Review.PMID: 17192926 [PubMed - indexed for MEDLINE]Related articles

    27.

    Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

    Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM.

    Neurology. 2007 Jan 30;68(5):384-6. Epub 2006 Nov 2.PMID: 17082464 [PubMed - indexed for MEDLINE]Related articles

    28.

    Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients.

    Kelly AG, Holloway RG.

    ACP J Club. 2006 Nov-Dec;145(3):77. No abstract available. PMID: 17080989 [PubMed]Related articles

    29.

    There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies.

    Johnston KC, Holloway RG.

    Neurology. 2006 Sep 12;67(5):740-1. No abstract available. Erratum in: Neurology. 2008 Jul 8;71(2):152. PMID: 16966532 [PubMed - indexed for MEDLINE]Related articles

    30.

    Biomarkers in Parkinson's disease.

    Dorsey ER, Holloway RG, Ravina BM.

    Expert Rev Neurother. 2006 Jun;6(6):823-31. Review.PMID: 16784406 [PubMed - indexed for MEDLINE]Related articles

    31.

    What is the risk of developing parkinsonism following neuroleptic use?

    Noyes K, Liu H, Holloway RG.

    Neurology. 2006 Mar 28;66(6):941-3.PMID: 16567720 [PubMed - indexed for MEDLINE]Related articles

    32.

    Update in neurology.

    Holloway RG Jr, Józefowicz RF.

    Ann Intern Med. 2006 Mar 21;144(6):421-6. Review. No abstract available. PMID: 16549854 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Volunteering for early phase gene transfer research in Parkinson disease.

    Kim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K.

    Neurology. 2006 Apr 11;66(7):1010-5. Epub 2006 Mar 15.PMID: 16540601 [PubMed - indexed for MEDLINE]Related articles

    34.

    Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.

    Noyes K, Dick AW, Holloway RG; Parkinson Study Group.

    Value Health. 2006 Jan-Feb;9(1):28-38.PMID: 16441522 [PubMed - indexed for MEDLINE]Related articles

    35.

    Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.

    Noyes K, Dick AW, Holloway RG; Parkinson Study Group.

    Pharmacoeconomics. 2005;23(12):1257-70.PMID: 16336019 [PubMed - indexed for MEDLINE]Related articles

    36.

    Prognosis and decision making in severe stroke.

    Holloway RG, Benesch CG, Burgin WS, Zentner JB.

    JAMA. 2005 Aug 10;294(6):725-33. Review.PMID: 16091575 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    How much is a good night's sleep worth?

    Williams LS, Holloway RG.

    Stroke. 2005 Jun;36(6):1293-4. No abstract available. PMID: 15914770 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report.

    Guttuso T Jr, Vitticore P, Holloway RG.

    J Neurosurg. 2005 Mar;102(3):547-9.PMID: 15796394 [PubMed - indexed for MEDLINE]Related articles

    39.

    Evidence from cost-effectiveness research.

    Noyes K, Holloway RG.

    NeuroRx. 2004 Jul;1(3):348-55. Review.PMID: 15717037 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Evidence-based neurotherapeutics: a spectrum of evidence.

    Holloway RG, Siderowf AD.

    NeuroRx. 2004 Jul;1(3):295-7. No abstract available. PMID: 15717030 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

    Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease.

    Mov Disord. 2004 Sep;19(9):1020-8.PMID: 15372591 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial.

    Noyes K, Dick AW, Holloway RG; Parkinson Study Group.

    Med Decis Making. 2004 Sep-Oct;24(5):472-85.PMID: 15358996 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

    Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A; Parkinson Study Group.

    Arch Neurol. 2004 Jul;61(7):1044-53. Erratum in: Arch Neurol. 2005 Mar;62(3):430. PMID: 15262734 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Surrogate endpoints in Parkinson's disease research.

    Biglan KM, Holloway RG.

    Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20. Review.PMID: 12930701 [PubMed - indexed for MEDLINE]Related articles

    46.

    Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis.

    Kim SY, Holloway RG.

    Am J Psychiatry. 2003 Jul;160(7):1272-6.PMID: 12832241 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Development and testing of the Parkinson's disease quality of life scale.

    Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J; Parkinson Study Group.

    Mov Disord. 2003 Jun;18(6):637-45.PMID: 12784266 [PubMed - indexed for MEDLINE]Related articles

    48.

    A Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist.

    Nodera H, Herrmann DN, Holloway RG, Logigian EL.

    Neurology. 2003 Feb 11;60(3):458-64.PMID: 12578927 [PubMed - indexed for MEDLINE]Related articles

    49.

    CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes.

    Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM.

    Radiology. 2002 Nov;225(2):441-9.PMID: 12409578 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.

    Biglan K, Holloway RG.

    Curr Neurol Neurosci Rep. 2001 Jul;1(4):329-36. Review.PMID: 11898538 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...